Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 7/20 | 0.61 |
| ▸ | RAB9A | P51151 | 2/20 | 0.61 |
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | HPGD | P15428 | 4/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.56 |
| ▸ | POLB | P06746 | 4/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 4/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | AR | P10275 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16502112 | 0.90 | MAPT (0.61) | MAPTL3MBTL1RAB9AATMHPGD | |
| SCHEMBL7634998 | 0.89 | ACHE (0.68) | MAPTL3MBTL1RAB9AATMHPGD | |
| SCHEMBL7903433 | 0.89 | ACHE (0.68) | MAPTL3MBTL1RAB9AATMHPGD | |
| SCHEMBL2477340 | 0.86 | MAPT (0.53) | MAPTL3MBTL1RAB9AATMHPGD | |
| SCHEMBL3069940 | 0.85 | L3MBTL1 (0.65) | MAPTL3MBTL1RAB9AATMHPGD | |
| SCHEMBL20005765 | 0.85 | MAOB (0.54) | MAPTL3MBTL1RAB9AATMHPGD | |
| SCHEMBL2611833 | 0.85 | MAPT (0.75) | MAPTL3MBTL1RAB9AATMHPGD | |
| SCHEMBL13020111 | 0.84 | MAPT (0.51) | MAPTL3MBTL1RAB9AATMHPGD | |
| SCHEMBL13019317 | 0.84 | MAPT (0.47) | MAPTL3MBTL1RAB9AATMHPGD | |
| SCHEMBL144438 | 0.84 | KDM4E (0.53) | MAPTL3MBTL1RAB9AATMHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 133 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060189614-A1 | Substituted diamino-1,3,5-triazine derivatives | JANSSEN PAUL A | 2006-08-24 | — | — | US | claimed |
| US-20060049177-A1 | Induction heating cooker | LG ELECTRONICS INC. | 2006-03-09 | — | — | US | claimed |
| EP-1214300-B1 | RATE-CONTROLLED PARTICLES | ABBOTT GMBH & CO KG (DE) | 2003-09-03 | — | — | EP | claimed |
| EP-0834507-A1 | Substituted diamino-1,3,5-triazine derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1998-04-08 | — | — | EP | claimed |
| US-4272634-A | Process for the production of intermediate oxidation products of toluenes having ether linkages | DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1981-06-09 | — | — | US | claimed |
| CN-112980307-A | Wear-resistant gear shaft and production process thereof | 台州格凌机械股份有限公司 | 2021-06-18 | — | — | CN | disclosed |
| US-20200216721-A1 | ADHESIVE SHEET HAVING EXCELLENT ULTRAVIOLET BLOCKING FUNCTION, ADHESIVE COMPOSITION, AND DISPLAY DEVICE COMPRISING SAME | LMS CO., LTD. (KR) | 2020-07-09 | — | — | US | disclosed |
| US-10501413-B2 | Inhibitors of the Notch transcriptional activation complex and methods for use of the same | UNIVERSITY OF MIAMI (US) | 2019-12-10 | — | — | US | disclosed |
| US-20180086700-A1 | INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-03-29 | — | — | US | disclosed |
| US-20170267630-A1 | CLASS-AND ISOFORM-SPECIFIC HDAC INHIBITORS AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2017-09-21 | — | — | US | disclosed |
| US-20170204073-A1 | COMPOUNDS FOR NONSENSE SUPPRESSION, AND METHODS FOR THEIR USE | PTC THERAPEUTICS, INC. (US) | 2017-07-20 | — | — | US | disclosed |
| US-20170174639-A1 | EIS INHIBITORS | UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION | 2017-06-22 | — | — | US | disclosed |
| EP-0834507-A1 | Substituted diamino-1,3,5-triazine derivatives | JANSSEN PHARMACEUTICA N.V. (BE) | 1998-04-08 | — | — | EP | disclosed |
| US-4272634-A | Process for the production of intermediate oxidation products of toluenes having ether linkages | DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1981-06-09 | — | — | US | disclosed |
| US-4255574-A | REACTING B-ALKOXY-PROPIONITRILE WITH AN ALKALI METAL ALCOHOLATE AND CONDENSING THE REACTION PRODUCT WITH GUANIDINE | HOFFMANN-LA ROCHE INC. (US) | 1981-03-10 | — | — | US | disclosed |
| US-4220605-A | LIQUID PHASE USING A SOLVENT OF LOW LOWER CARBOXYLIC ACID OR ANHYDRIDE, A SOLUBLE COBALT SALT AND BROMINE OR A BROMINE COMPOUND | DIRECTOR GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1980-09-02 | — | — | US | disclosed |
| US-4143227-A | FROM THE 2,4-DIAMINO-5-OXY OR HALOMETHYL-PYRIMIDINE AND A 1,2-DIALKOXY OR METHYLENEDIOXY-BENZENE IN AN ACID | HOFFMANN-LA ROCHE INC. (US) | 1979-03-06 | — | — | US | disclosed |
| US-4029699-A | CHOLERETIC ACTIVITY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1977-06-14 | — | — | US | disclosed |
| US-4017517-A | SPASMOLYTIC, CHOLERETIC | TAKEDA CHEMICAL INDUSTRIES, LTD. (JA) | 1977-04-12 | — | — | US | disclosed |
| US-3943169-A | DIURETIC, SPASMOLYTIC | TAKEDA CHEMICAL INDUSTRIES, LTD (JA) | 1976-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174639-A1 | EIS INHIBITORS | ABCC1, ATP5ME, ABCG2 | MAPT 3708/4885L3MBTL1 4157/4885RAB9A 1021/4885 |
| US-10501413-B2 | Inhibitors of the Notch transcriptional activation complex and methods for use of the same | NOTCH1, CBFB, HES1 | MAPT 3938/4885L3MBTL1 805/4885RAB9A 3454/4885 |
| US-20170204073-A1 | COMPOUNDS FOR NONSENSE SUPPRESSION, AND METHODS FOR THEIR USE | NSUN2, UPF1, NSUN3 | MAPT 3781/4885L3MBTL1 67/4885RAB9A 2618/4885 |
| US-20060189614-A1 | Substituted diamino-1,3,5-triazine derivatives | C5, ADORA1, C1S | MAPT 3917/4885L3MBTL1 1324/4885RAB9A 626/4885 |
| US-20180086700-A1 | INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME | NOTCH1, CBFB, HES1 | MAPT 3938/4885L3MBTL1 805/4885RAB9A 3454/4885 |
| US-20170267630-A1 | CLASS-AND ISOFORM-SPECIFIC HDAC INHIBITORS AND USES THEREOF | HDAC1, HDAC5, HDAC6 | MAPT 3262/4885L3MBTL1 2029/4885RAB9A 4104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.